Atorvastatin Calcium
Product Images NDC 60760-709

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

At] (Atorvastatin 60760 709 30)

At] (Atorvastatin 60760 709 30)
This is a description of a medication called Atorvastatin Calcium. These are tablets that come in a strength of 40 mg, with 30 tablets per container. The manufacturer is Alkem Laboratories Ltd. from Mumbai, India. The lot and expiration dates are not entirely clear. The medication is packaged by "Valley Managed Pharmacy Programs". The text includes information about how to store the medication and a warning to use only as directed. The National Drug Code (NDC) for the medication is 60760-709-30.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
The text is describing the cumulative hazard percentage of a placebo and atorvastatin, showing the time to the first primary endpoint over four years of follow-up. The hazard ratio for atorvastatin is also provided.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
The table shows the percentage of subjects experiencing an event while taking either Atorvastatin at a dose of 10mg or 80mg. The HR (hazard ratio) for taking Atorvastatin at 80mg compared to not taking it was 0.78, which means there was a decreased risk of a major cardiovascular endpoint. The graph shows the time to the first major cardiovascular endpoint in years.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.